atyrpharma.com | A new path to medicine

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://atyrpharma.com/sitemap_index.xml # --------------------------- # END YOAST

Meta Tags

Title	A new path to medicine - aTyr
Description	Translating tRNA synthetase biology into a new class of
Keywords	N/A

Server Information

WebSite	atyrpharma.com
Host IP	34.74.20.137
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

augustalandscapingllc.com

autoaccessoryconfigurator.com

autobahnaccessories.com

autobodyxperts.com

atyrpharma.com Valuation

US$13,824,053

Last updated: 2023-05-09 07:31:52

atyrpharma.com has Semrush global rank of 765,644. atyrpharma.com has an estimated worth of US$ 13,824,053, based on its estimated Ads revenue. atyrpharma.com receives approximately 1,595,084 unique visitors each day. Its web server is located in United States, with IP address 34.74.20.137. According to SiteAdvisor, atyrpharma.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$13,824,053
Daily Ads Revenue	US$12,761
Monthly Ads Revenue	US$382,820
Yearly Ads Revenue	US$4,593,840
Daily Unique Visitors	106,339
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
atyrpharma.com.	A	3599	IP: 34.74.20.137
atyrpharma.com.	NS	3600	NS Record: ns25.domaincontrol.com.
atyrpharma.com.	NS	3600	NS Record: ns26.domaincontrol.com.
atyrpharma.com.	MX	3600	MX Record: 10 ALT3.ASPMX.L.GOOGLE.com.
atyrpharma.com.	MX	3600	MX Record: 10 ALT4.ASPMX.L.GOOGLE.com.
atyrpharma.com.	MX	3600	MX Record: 1 ASPMX.L.GOOGLE.com.
atyrpharma.com.	MX	3600	MX Record: 5 ALT1.ASPMX.L.GOOGLE.com.
atyrpharma.com.	MX	3600	MX Record: 5 ALT2.ASPMX.L.GOOGLE.com.
atyrpharma.com.	TXT	3600	TXT Record: v=spf1 ip4:104.200.146.217 ip4:34.74.20.137 include:_spf.google.com ~all
atyrpharma.com.	TXT	3600	TXT Record: google-site-verification=abLQG8JQ2_vV2n-ooaJ7H8bUmK4OYodvP5BPiW3M4DM
atyrpharma.com.	TXT	3600	TXT Record: google-site-verification=CrBgfojyoZCkk3wtI3VWqttP8fb85zyBTOkLz9AfbyU
atyrpharma.com.	TXT	3600	TXT Record: 0ed1fe018ae4a6c81c8748415991cd6f789f532a24

HtmlToTextCheckTime:2023-05-09 07:31:52

NASDAQ: LIFE --> --> Pangu Contact Clinical Trials Patients Primary Menu Company About Us Leadership Team Board of Directors Contact Our Science tRNA SYNTHETASE BIOLOGY NRP2 Biology Intellectual Property Publications, Posters and Presentations R&D Pipeline Efzofitimod (ATYR1923) ATYR2810 Discovery Programs Pangu Patients Clinical Trials About Pulmonary Sarcoidosis Expanded Access Policy Careers Working at aTyr Career Opportunities Investors and Media News Releases SEC Filings Stock Information Events and Webcasts Investor Alerts Corporate Governance Analyst Coverage Media A new path to medicine Translating tRNA synthetase biology into a new class of medicines --> © 2007 - 2023 aTyr Pharma. Legal Privacy Policy By continuing to browse this site, you agree to our use of cookies . I understand MENU Company About Us Leadership Team Board of Directors Contact Our Science Extracellular t RNA Synthetase Biology NRP2 Biology Intellectual Property Publications, Posters and

HTTP Headers

HTTP/1.1 301 Moved Permanently
Server: nginx
Date: Sun, 31 Oct 2021 11:56:41 GMT
Content-Type: text/html
Content-Length: 162
Connection: keep-alive
Keep-Alive: timeout=20
Location: https://atyrpharma.com/

HTTP/2 200 
server: nginx
date: Sun, 31 Oct 2021 11:56:42 GMT
content-type: text/html; charset=UTF-8
content-length: 35006
vary: Accept-Encoding
vary: Accept-Encoding
x-content-type-options: nosniff
link: ; rel="https://api.w.org/"
link: ; rel="alternate"; type="application/json"
link: ; rel=shortlink
x-powered-by: WP Engine
x-frame-options: DENY
x-xss-protection: 1
strict-transport-security: max-age=31536000
referrer-policy: no-referrer-when-downgrade
x-cacheable: SHORT
vary: Accept-Encoding,Cookie
cache-control: max-age=600, must-revalidate
x-cache: HIT: 1
x-cache-group: normal
accept-ranges: bytes

atyrpharma.com Whois Information

Domain Name: ATYRPHARMA.COM
Registry Domain ID: 196970424_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2021-08-17T14:52:38Z
Creation Date: 2005-08-16T20:06:46Z
Registry Expiry Date: 2022-08-16T20:06:46Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS25.DOMAINCONTROL.COM
Name Server: NS26.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-18T21:49:04Z <<<

atyrpharma.com valuation and analysis